Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crossroad Fund
Indianapolis, Indiana, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
BioCrossroads is an Indiana-based life sciences venture capital organization founded in 2005. It manages Seed Funds, such as Indiana Seed Fund III (nearly $24M AUM in 2018), to invest in early-stage biotechnology, pharmaceutical, medical device, diagnostics, ag-biotech, and health IT companies. The organization plays a crucial role in supporting Indiana's life sciences sector, which was recognized as a top U.S. exporter in 2024. Its portfolio companies have collectively raised over $500M in additional funding, with notable exits including Calibrium, MB2 (acquired by Novo Nordisk), Assembly Biosciences (Nasdaq:ASMB), and Sexton Biotechnologies (acquired by BioLife Solutions).
- Industry
- Investors
02
Partnerships
Indiana corporate and academic life sciences leadershipIndiana research institutionsGlobal companiesPhilanthropic organizationsGovernment
Beyond the preview
Go deeper on Crossroad Fund.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Crossroad Fund.